University of Cincinnati

11/18/2026 | Press release | Distributed by Public on 11/18/2026 13:03

New guidance targets dangerous ‘rhino tranq’ withdrawal

New guidance targets dangerous 'rhino tranq' withdrawal

UC emergency medicine experts featured in Medscape article

2 minute read November 18, 2026 Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Print Story Like

The University of Cincinnati's M. Ross Lawson and Richard Ryan spoke with Medscape about new American Society of Addiction Medicine (ASAM) clinical guidance on managing intoxication and potentially life-threatening complications from withdrawal associated with medetomidine, also known as "rhino tranq."

The potent drug designed as a veterinary sedative was first detected in the American illicit opioid supply in 2021, with the highest prevalence in the Midwest and Northeast. Withdrawal symptoms can begin within four to six hours of last use, earlier than typical fentanyl withdrawal symptoms.

"That rapid progression can catch clinicians off guard," Lawson, MD, assistant professor of addiction medicine and emergency medicine at UC's College of Medicine, who served as a field reviewer of the guidance, told Medscape Medical News. He noted the new guidelines are a "much needed resource," particularly for clinicians working in regions that have not experienced widespread medetomidine exposure.

Ryan, MD, professor of emergency medicine at UC's College of Medicine, said a "careful, nonjudgmental" substance use history and remaining informed about local drug trends can help physicians identify medetomidine withdrawal when its symptoms can look similar to alcohol, opioid and other drug withdrawals.

"I truly believe we are undertreating patients experiencing medetomidine withdrawal," Ryan said. "Education of physicians and providers is the key. "Bottom line, much education still needs to be done in how to properly take care of these patients."

Read the Medscape article.

Featured photo at top of UC Health's Emergency Department entrance. Photo/UC Health.

Related Stories

1

UC researcher to launch national study with $2.5 million NIH grant

October 9, 2026

A University of Cincinnati researcher has received a $2.5 million National Institutes of Health grant to conduct research during the next five years. Natalie Kreitzer, MD, a University of Cincinnati College of Medicine physician-researcher, received an R01 independent research grant from the NIH's Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funding will support a test program for caregivers of patients with traumatic brain injury, as reported by the Cincinnati Business Courier.

2

UC marks 4 years saving lives with mobile stroke unit

August 15, 2024

The University of Cincinnati's Christopher Richards spoke with Local 12 about the four-year anniversary of the mobile stroke unit that can bring the emergency department directly to patients.

3

Optimizing emergency care for neurotrauma patients

July 2, 2025

The University of Cincinnati's Natalie Kreitzer, MD, was featured in an Emergency Medicine News article discussing new practices to optimize emergency care for patients with traumatic brain injuries.

University of Cincinnati published this content on November 18, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 19:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]